Meloxicam v bedinvetmab (Librela). Real world data and insights from a UK comparative field study

This study will report the FIRST comparitor clinical trial of bedinvetmab v meloxicam for the alleviation of pain associated with canine osteoarthritis. This was a multi-centre, open label, randomised clinical trial in over 100 dogs. Efficacy was measured with the Canine Orthopedic Index and adverse events were recorded. Per protocol and intent-to-treat analyses were performed for efficacy and safety. Come along to hear the results!

15 Nov 2024
11:30 - 12:15
Platinum Suite - Level 3

Presented at London Vet Show 2024

Please note this session is not RACE-approved but you can still earn a CPD certificate